The Changing Paradigms for Breast Cancer Surgery: Performing Fewer and Less-Invasive Operations

David W. Ollila, E. Shelley Hwang, David R. Brenin, Henry M. Kuerer, Katharine Yao, Sheldon M. Feldman

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Historically, through the conduct of prospective clinical trials, breast cancer surgeons have performed less radical breast and axillary surgeries with no survival decrement to our patients. Currently, other opportunities exist for the treating breast surgeon to do less. Possibilities include active surveillance for ductal carcinoma in situ, ablative therapy for small primary breast cancers, selective omission of a sentinel node biopsy, and selective elimination of breast surgery after neoadjuvant systemic therapy. Breast surgeons must be leaders in the development and testing of effective therapy with the least intervention possible.

Original languageEnglish (US)
Pages (from-to)1-6
Number of pages6
JournalAnnals of Surgical Oncology
DOIs
StateAccepted/In press - Jul 2 2018

    Fingerprint

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this